Abstract
Inhibition of the mitochondrial Na+/Ca2+ exchanger (NCLX) by CGP37157 is protective in models of neuronal injury that involve disruption of intracellular Ca2+ homeostasis. However, the Ca2+ signaling pathways and stores underlying neuroprotection by that inhibitor are not well defined. In the present study, we analyzed how intracellular Ca2+ levels are modulated by CGP37157 (10 μM) during NMDA insults in primary cultures of rat cortical neurons. We initially assessed the presence of NCLX in mitochondria of cultured neurons by immunolabeling, and subsequently, we analyzed the effects of CGP37157 on neuronal Ca2+ homeostasis using cameleon-based mitochondrial Ca2+ and cytosolic Ca2+ ([Ca2+]i) live imaging. We observed that NCLX-driven mitochondrial Ca2+ exchange occurs in cortical neurons under basal conditions as CGP37157 induced a decrease in [Ca2]i concomitant with a Ca2+ accumulation inside the mitochondria. In turn, CGP37157 also inhibited mitochondrial Ca2+ efflux after the stimulation of acetylcholine receptors. In contrast, CGP37157 strongly prevented depolarization-induced [Ca2+]i increase by blocking voltage-gated Ca2+ channels (VGCCs), whereas it did not induce depletion of ER Ca2+ stores. Moreover, mitochondrial Ca2+ overload was reduced as a consequence of diminished Ca2+ entry through VGCCs. The decrease in cytosolic and mitochondrial Ca2+ overload by CGP37157 resulted in a reduction of excitotoxic mitochondrial damage, characterized here by a reduction in mitochondrial membrane depolarization, oxidative stress and calpain activation. In summary, our results provide evidence that during excitotoxicity CGP37157 modulates cytosolic and mitochondrial Ca2+ dynamics that leads to attenuation of NMDA-induced mitochondrial dysfunction and neuronal cell death by blocking VGCCs.
Similar content being viewed by others
Main
Mitochondria regulate critical functions such as aerobic ATP production and cell survival by buffering cytosolic Ca2+ in physiological normal conditions. Conversely, mitochondrial dysfunction and Ca2+ overload occur in pathological conditions that involve a disruption of intracellular Ca2+ homeostasis, such as neurodegenerative disorders and ischemic injury.1 Mitochondria modulate intracellular Ca2+ signaling with a complex toolkit for Ca2+ uptake and release recently characterized at the molecular level.2 Thus, Ca2+ accumulation inside mitochondrial matrix, driven by the mitochondrial Ca2+ uniporter (MCU), is similar in most cell types, whereas excitable and non-excitable tissues may differ in Ca2+ efflux mechanisms.3 In neurons, mitochondrial Ca2+ is predominantly released by an Na+/Ca2+ exchanger (NCLX) that is Li+ dependence,4 and it is specifically inhibited by the benzothiazepine CGP37157.5, 6 Although it is well established that mitochondrial Ca2+ extrusion by NCLX contributes considerably to the control of Ca2+-dependent functions, little is known about the relevance of its activity to neuropathophysiology, and it remains controversial whether pharmacological inhibition of the exchanger attenuates tissue damage in ischemic or neurodegenerative conditions.7 Indeed, CGP37157 was shown to protect hippocampal slices against cytosolic Ca2+ and Na+ overload8 whereas in a PINK-1-associated Parkinson’s Disease model, inactivation of the mitochondrial Na+/Ca2+ exchanger contributed to mitochondrial Ca2+ overload and turned out to be detrimental.9
Overactivation of NMDA receptors (NMDARs) is considered to have a key role in glutamate-induced excitotoxicity in neurons of the CNS,10 and the underlying mechanism is dependent on (i) mitochondrial Ca2+ uptake,11 which leads to mitochondrial dysfunction and cell death12, 13 and (ii) cytosolic Ca2+ overload, which might trigger neuronal necrosis and apoptosis by the activation of calpains.14 In addition, Ca2+ elevations depolarize plasma membrane and open VGCCs that critically contribute to excitotoxicity.15, 16 However, it is unclear whether inhibition of the NCLX by CGP37157 and its associated signaling is neuroprotective. In this study, we have analyzed the effect of CGP37157 on NMDA-induced neuronal death and the mechanisms by which this NCLX inhibitor regulates cytosolic and mitochondrial Ca2+ signals during excitotoxicity in vitro. Our results show that benzothiazepine CGP37157 inhibits the mitochondrial Na+/Ca2+ exchanger in cortical neurons in basal conditions, and that it prevents from NMDA-induced cytosolic and mitochondrial Ca2+ overload and cell death by modulating Ca2+ entry through VGCCs.
Results
NCLX is expressed in cultured primary cortical neurons
Previous reports have shown that NCLX is predominantly localized in the mitochondrial fraction of brain tissue as molecular forms of 50 and 70 kDa, together with an SDS-resistant 100 kDa dimer.4 In addition, the exchanger has been localized as well to the endoplasmic reticulum and plasma membrane17 and its expression and subcellular localization in different cell types of the central nervous system has not been analyzed so far. To determine whether NCLX is present in mitochondria in cultured primary cortical neurons, we carried out the immunolabeling of this exchanger in cells transfected with mitochondria-targeted DsRed (Figure 1a). Confocal microscopy analysis showed a positive staining for the NCLX (green) in cortical neurons which colocalizes with red mitochondria according to the fluorescence intensity analysis of the neuronal cross-section (Figure 1b) and overlap coefficient (0.78±0.01, n=32 cells). Furthermore, immunoblotting analysis confirmed the expression of the 50 and 70 kDa forms of the mitochondrial Na+/Ca2+ exchanger in the neuronal cultures used in this study (Figure 1d), indicating that these cells express in vitro the NCXL protein described before in brain extracts.
CGP37157 inhibits mitochondrial Na+/Ca2+ exchanger in cortical neurons
The benzothiazepine compound CGP37157 has been widely considered a specific inhibitor of mitochondrial Na+/Ca2+ exchanger (at 10 μM or below) in several cell types,6, 18 but its specificity remains controversial. CGP37157 was shown to regulate VGCCs in dorsal root ganglion neurons19 and pancreatic β cells20 whereas in these cells a selective inhibition of NCLX in vivo and in vitro was previously demonstrated.21 In addition, CGP37157 was also described to induce ER Ca2+ depletion by ryanodine receptor activation and to inhibit the endoplasmic reticulum Ca2+ ATP-ase (SERCA) in skeletal and cardiac muscle.22 To assess the effects of CGP37157 on mitochondrial Ca2+ homeostasis, cortical neurons were transfected with the genetically encoded Ca2+ indicator 2mtD4cpv (Figure 2a) and FRET signal recorded by single cell confocal imaging. Addition of CGP37157 caused a slow accumulation of mitochondrial Ca2+ that reached a 115.7±2.2% (n=23) of baseline levels (100%) after 10 min (Figure 2b). Treatment of neurons with CGP37157 for 1 h increased the mitochondrial Ca2+ levels to 137.5±7.8% (n=94) compared with control (untreated cells, 100%, n=112) (Figure 2c). Concomitantly with this mitochondrial Ca2+ ([Ca2+]mit) increase, intracellular Ca2+ levels ([Ca2+]i) fell rapidly to a 90% (n=51) compared with resting Ca2+ levels (100%), as observed in Fluo-4 AM-loaded neurons (Figure 2d). On the other hand, cytosolic Na+ levels ([Na+]i) reached a 117.7±1.7% (n=86) of basal content (100%) during 10 min after addition of CGP37157 in neurons loaded with sodium green fluorescent dye (Figure 2e). Application of 1 mM of acetylcholine (ACh) to neurons was used to analyze whether NCLX conducts mitochondrial Ca2+ efflux. Agonist caused mitochondrial Ca2+ transients characterized by a fast initial influx resulting in an increase of 131.1±3.2% (n=33) of resting Ca2+ levels that was followed by an efflux (at a rate of 130±24 × 10−3/s) during exposure to the agonist (Figures 2f and g). Stimulation of acetylcholine receptors in the presence of CGP37157 prevented Ca2+ efflux (rate −2.8±8.5 × 10−3/s, n=30) (Figures 2f–h). Interestingly, acetylcholine-induced [Ca2+]mit increase was also reduced by CGP37157 to 117.3±1.8% suggesting that it may modulate Ca2+ entry as well from the extracellular space (Figures 2f and g).
CGP37157 modulates intracellular Ca2+ levels through the inhibition of voltage-gated calcium channels
CGP37157 may cause blockade of cell Ca2+ entry by Ca2+ channels in high K+-depolarized SH-SY5Y cells.23 Therefore, we examined whether CGP37157 modulates VGCCs in depolarization-induced neuronal Ca2+ currents in both cytosol and mitochondria of cortical neurons. Application of KCl (50 mM, 10 min) induced a fast [Ca2+]i increase with a peak amplitude of 293.1±14% (n=58) compared with resting levels (100%) that was reduced in a dose-dependent manner by 10 and 50 μM nifedipine to 222.2±7.3% (n=89) and 184.9±6% (n=70), respectively (Figure 3a). Similarly, the [Ca2+]i increase induced by KCl was reduced by CGP37157 (peak amplitude of 199.8±6.5%; n=84) (Figure 3a). Moreover, we observed that CGP37157 reduced the depolarization-induced [Ca2+]mit increase in neurons transfected with the mitochondria-targeted cameleon. Thus, KCl provoked a mitochondrial Ca2+ accumulation (peak amplitude of 153.9±4.6%; n=22) compared with resting levels (100%) after 10 min stimulation that was robustly reduced by CGP37157 (peak amplitude of 120.3±3.2%; n=31) (Figure 3b). Finally, we analyzed whether CGP37157 induced ER Ca2+ depletion either in the long term, presumably by preventing store-refilling, or by inducing Ca2+ release through ryanodine receptors. First, 10 μM of CGP37157 was added to neurons in the absence of extracellular Ca2+ and no [Ca2+]i increase was observed, whereas thapsigargin, an inhibitor of the ER SERCA pump, swiftly increased the [Ca2+]i to 181±13% (n=86) of basal Ca2+ content (100%) (Figure 3c). To determine whether CGP37157 could contribute to depleting or preventing the refilling of intracellular stores, thapsigargin-induced [Ca2+]i increases were compared in control neurons and in neurons pre-incubated with CGP37157. We found no significant differences in the peak responses (127.9±2.9%, n=85, and 130.9±3%, n=80, respectively (Figure 3d). Taken together, these results indicate that CGP37157 blocks both NCLX and VGCCs in neurons whereas it does not contribute to depletion of ER Ca2+ stores.
NMDA-induced cytosolic and mitochondrial Ca2+ overloads are reduced by CGP37157
Selective inhibition of NCLX by CGP37157 results in increased [Ca2+]mit after ATP-mediated intracellular Ca2+ release in astrocytes.24 In neurons, activation of NMDA receptors results in a privileged Ca2+ access to mitochondria.25 To analyze whether CGP37157 modulates mitochondrial Ca2+ homeostasis during NMDA receptor-mediated excitotoxicity, neurons were stimulated with NMDA in the presence of the Na+/Ca2+ exchanger blocker and [Ca2+]mit measured by the mitochondria-targeted Ca2+ indicator. In control cells, NMDA (30 μM, 5 min) led to a maximum [Ca2+]mit increase of 198.3±6.6% (n=33) compared with resting Ca2+ levels (100%) (Figure 4a). Interestingly, in neurons pre-incubated with CGP37157, [Ca2+]mit increase was strongly reduced to 150.9±4.9% (n=42) (Figure 4a). As CGP37157 reduced the depolarization-induced (evoked by high K+) [Ca2+]mit and [Ca2+]i increases, we next analyzed whether VGCCs contributed the NMDA-induced mitochondrial Ca2+ overload in this preparation. As expected, nifedipine (10 μM, 30 min) inhibited the [Ca2+]mit increase after NMDA application to 161.3±4.9% (n=41) (Figure 4a).
To verify that the effect of CGP37157 on mitochondrial Ca2+ signals was not due to the inhibition of a reverse NCLX activity during NMDA receptor activation, [Na+]i was measured in the same experimental conditions. In control cells, NMDA (30 μM) induced a [Na+]i increase of 127±1.6% (peak amplitude, n=99) of resting levels (100%) which was reduced in the presence of CGP37157 to 112.5±1.69% (peak amplitude, n=83). Nifedipine also attenuated NMDA-induced [Na+]i increase from 137.3±2.7% to 126.2±1.5% of basal levels (100%) (peak amplitude, n=68) (Figure 4b). These results suggested that the effect of CGP37157 on [Ca2+]mit during excitotoxicity relies on the modulation of the Ca2+ entry from the extracellular space more than in the modulation of the NCLX activity. To confirm this hypothesis, we next tested whether CGP37157 attenuated the depolarization-induced cytosolic Ca2+ load during NMDA stimuli in neurons. Neurons were loaded with Fluo-4 and the NMDA-induced [Ca2+]i increase was measured in the presence of CGP37157 or the VGCC inhibitor nifedipine. NMDA alone triggered a [Ca2+]i increase of 263.3±7.9% (n=91) compared with resting levels (100%), which was significantly reduced by nifedipine to 191.8±7.3% (n=68), indicating that VGCCs contribute to NMDA-induced [Ca2+]i overload (Figure 4c). Similarly to nifedipine, CGP37157 reduced the [Ca2+]i increase to 188.8±5.6% (n=102) after the application of NMDA (Figure 4c).
Thus, these results suggest that CGP37157 shapes cytosolic and mitochondrial Ca2+ signaling during excitotoxicity by modulating VGCCs rather than through a selective inhibition of the mitochondrial Na+/Ca2+ exchanger.
CGP37157 reduces NMDA-induced excitotoxicity by the attenuation of mitochondrial damage and calpain activity in neurons
Mitochondrial Ca2+ uptake is a critical step for NMDA receptor-mediated glutamate excitotoxicity,11 whereas mitochondrial Na+/Ca2+ exchanger inhibitor CGP37157 turned out to be neuroprotective in several models of Ca2+ overload.23 To study the effect of CGP37157 on NMDA-induced excitotoxicity, primary cultures of cortical neurons were exposed to the drug before and during application of NMDA (30 and 100 μM) and LDH release to the medium was quantified 24 h later. We observed a dose-dependent LDH release of 257.5±16.1% at NMDA 30 μM (n=7) and 404±40.9% at NMDA 100 μM (n=7) compared with control (untreated cells, 100%) that was significantly reduced by CGP37157 to 199.6±7.4% and 338.5±15.2%, respectively (Figure 5a). To verify whether VGCCs contributed to the NMDA-induced toxicity, neurons were exposed to 30 μM of NMDA in the presence of nifedipine (10 μM) which attenuated LDH release from 224.6±33.7% to 184.4±33.7% (n=6) (Figure 5b). Simultaneous incubation of neurons with nifedipine and CGP37157 did not reduce LDH release further (161.7±26.1%, n=6, nonsignificant versus each drug alone) (Figure 5c).
We had previously shown that NMDA-mediated toxicity involves mitochondrial membrane depolarization and generation of reactive oxygen species (ROS).26 Thus, we analyzed whether CGP37157 modulated NMDA-induced mitochondrial damage, as a consequence of the regulation of mitochondrial Ca2+ uptake during excitotoxicity. To measure the oxidative stress, cells were loaded with CM-H2DCFDA and ROS-induced fluorescence signal was quantified in 100 μM NMDA-treated neuronal cells. Excitotoxic stimuli increased ROS up to 142.1±15.6% (n=4) compared with untreated cells (100%) whereas the pre-incubation with CGP37157 reduced the generation of ROS by 52% (to 120.5±11.2% of control; Figure 5c). Next, we analyzed the effect of the NCLX inhibitor on mitochondrial membrane potential during excitotoxicity. Neurons were exposed to NMDA (100 μM, 10 min) and the mitochondrial depolarization measured 45 min later by the fluorescent dye JC-1. NMDA induced a 13.8±1.3% depolarization (to 86.1% of untreated cells 100%, n=4), which was attenuated by 50.7% in the presence of CGP37157 (to 92.9±2.9% of control, n=4; Figure 5d). Finally, to analyze whether CGP37157 regulates excitotoxic apoptosis we studied the activation/cleavage of caspase-3 in NMDA-stimulated neurons when the NCLX inhibitor was present. NMDA (30 μM, 30 min) triggered cleavage of pro-caspase-3 and production of a 29 kDa fragment (Figure 5e) previously identified as a calpain-produced caspase-3 intermediate.27, 28 In contrast to NMDA, staurosporine cleaved the caspase-3 proform to produce a 17 kDa fragment, as well as the caspase-3 specific target Poly-ADP-ribose polymerase (PARP) (Figure 5f), revealing different signaling pathways activated by each drug. In the presence of CGP37157, however, the NMDA-induced and calpain-mediated caspase-3 cleavage was diminished to 24.1±14.8% (n=4) of control (NMDA alone, 100%). In turn, since inhibition of VGCCs was previously shown to attenuate the apoptotic cascade in rat hippocampus during ischemia,29 we tested whether nifedipine alone was able to decrease the calpain-mediated caspase-3 cleavage in our excitotoxic model. Consistent with toxicity data, nifedipine reduced cleaved/pro-caspase-3 ratio to 59.9±10.9% (n=4) of control (100%). Thus, these results indicate that CGP37157 might protect neurons from NMDA-induced mitochondrial damage and calpain activity by modulating VGCCs.
Discussion
The NCLX inhibitor CGP37157 is neuroprotective8 and modulates cytosolic Ca2+ signaling30 in hippocampal slices. However, most studies describing the effects of CGP37157 during a neuronal Ca2+ dyshomeostasis were based on the analysis of [Ca2+]i, and whether NCLX inhibition contributes to neuroprotection in the experimental conditions assayed remains controversial. In this study, we demonstrate that CGP37157 inhibits the NCLX in basal conditions in neurons in vitro. In contrast, this drug modulates Ca2+ entry into the cytosol through VGCCs during membrane depolarization with KCl or NMDA receptor stimulation, which in the latter, prevents cells from excitotoxic mitochondrial Ca2+ overload and neuronal death. Thus, our results provide evidence of a new NCLX-independent neuroprotective mechanism of CGP37157 and calls into question its specificity as a NCLX inhibitor in experimental paradigms that involve neuronal depolarization and cytosolic Ca2+ overload.
Expression of NCLX in primary cultured neurons
Little is known about the expression and distribution of NCLX in the different cell types of the CNS. Yet, a recent study showed that astrocytes express the NCLX 50 kDa form and the 100 kDa dimer in mitochondria and that it has a major role in intracellular signaling, gliotransmission and proliferation.24 In cortical neurons in vitro, we found NCLX is also expressed in mitochondria, as assessed by double labeling immunofluorescence. In addition, immunoblotting revealed the presence of both the 50- and 70-kDa isoforms, which suggests a differential expression of NCLX species in the various cell types of the CNS. This raises the intriguing question as to whether the two alternatively spliced isoforms may subserve diverse functional properties. In addition, some of the NCLX staining does not colocalize with red mitochondria in DsRed positive cells, indicating that NCLX might be expressed in other compartments different to mitochondria in neurons, as described before in HEK-293 cells.17
Effects of CGP37157 on neuronal Ca2+ homeostasis
The benzothiazepine CGP37157 inhibits the mitochondrial Na+/Ca2+ exchange with a 10 to 20-fold higher affinity than other analogs like diltiazem and clonazepam31 and to date, it remains as the only effective and relatively specific drug to target the NCLX.18 Thus, CGP37157 at 10 and 20 μM inhibits mitochondrial Ca2+ efflux following an ATP stimulus in SHSY-5Y cells4 and astrocytes.24 Our results in resting neurons show that CGP37157 at that concentration causes a concomitant increase and decrease in intracellular Na+and Ca2+, which is consistent with an inhibition of the NCLX. In addition, we provide evidence that CGP37157 inhibits mitochondrial Ca2+ efflux after ACh receptor activation in cultured neurons. Interestingly, ACh-induced mitochondrial Ca2+ influx was also significantly reduced in the presence of CGP37157, an unexpected effect for a mitochondrial Na+/Ca2+ exchanger inhibition that suggest additional interactions for this drug. Indeed, there is some evidence that CGP37157 may inhibit L-type VGCCs in dorsal root ganglion neurons and SH-SY5Y cells19, 23 and that it directly regulates ER Ca2+ uptake and release in striated muscle.22 Because of that, we tested the effects of CGP37157 on VGCCs and found that CGP37157 efficiently blocks high K+-induced [Ca2+]i increase in neurons, with an efficacy similar to that of the VGCC inhibitor nifedipine. Moreover, we found that depolarization induces a [Ca2+]mit increase that is reduced as well by CGP37157. Importantly, nifedipine-reduced as well acetylcholine-induced mitochondrial Ca2+ transient but not the Ca2+ efflux, which confirms that the Ca2+ efflux inhibition is a specific effect provided by CGP37157 (data not shown). However, ER Ca2+ release values, indicative for ER Ca2+ content, suggest that CGP37157 does not contribute to ER store depletion in resting neurons. In turn, the [Ca2+]i increase following the thapsigargin-induced initial Ca2+ transient was absent in CGP37157-treated neurons, which might be due to a modulation of the store-operated Ca2+ entry (SOCE) by NCLX activity, an effect that was recently described in astrocytes.24
CGP37157 modulates NMDA-induced cytosolic and mitochondrial Ca2+ overloads
Glutamate excitotoxicity contributes to many brain pathologies such as ischemia and traumatic brain injury via NMDA receptor-mediated Ca2+ signaling.32 CGP37157 regulates glutamate-induced cytosolic Ca2+ transients by the selective inhibition of the mitochondrial Na+/Ca2+ exchanger in neurons,33 but little is known about how this NCLX inhibitor modulates mitochondrial Ca2+ signaling during NMDA receptor-mediated excitotoxicity. Again, we observed that intracellular Ca2+ measurements during NMDA application in presence of the CGP37157 were not consistent with a specific inhibition of the NCLX. In agreement with previous observations in hippocampal slices subjected to an Na+ and Ca2+ overload,8 we found that CGP37157 reduces significantly the excitotoxic [Ca2+]i increase, as expected from an NCLX inhibition. However, we found that [Ca2+]mit and [Na+]i were reduced as well, indicating that CGP37157 blocks Ca2+ entry from the extracellular space rather than inhibiting the mitochondrial Na+/Ca2+ exchanger. Indeed, previous studies suggested that CGP37157 does not potentiate neuronal mitochondrial Ca2+ uptake during glutamate insults, as evaluated by indirect [Ca2+]mit analysis.34 In contrast, it was recently described that mitochondrial Ca2+ accumulation is increased by CGP37157 as a result of NCLX inhibition during exposure to ATP in astrocytes.24 However, this selective effect of CGP37157 was observed after metabotropic receptor stimulation and thus in conditions that primarily do not involve significative extracellular Ca2+ entry.
As CGP37157 blocked VGCCs in neurons, we tested whether these channels contributed to NMDA-induced intracellular Ca2+ loads in vitro. Nifedipine, like CGP37157, reduced NMDA-induced cytosolic Ca2+ and Na+ loads, as well as [Ca2+]mit increase. These data demonstrate the recruitment of VGCCs in NMDA-induced Ca2+ signals, and strongly suggest that CGP37157 attenuates cytosolic and mitochondrial Ca2+ overload as a consequence of the negative modulation of these channels.
CGP37157 protects neurons from mitochondrial damage and cell death
Mitochondrial Ca2+ overload and subsequent mitochondrial membrane potential collapse are critical events in excitotoxic neuronal death,35 and this premise predicts that the inhibition of mitochondrial Ca2+ efflux would make cells more vulnerable against an intracellular Ca2+ overload. Nevertheless, Nicolau et al.8 showed that CGP37157 protected hippocampal slices against veratridine-induced Ca2+ and Na+ overload by regulating the oxidative stress and p38 MAPK-linked death pathway. Our results indicate as well that CGP37157 protects cortical neurons against excitotoxicity. CGP37157 reduced NMDA-induced oxidative stress and mitochondrial membrane depolarization, likely by attenuating mitochondrial Ca2+ overload. In addition, preventing the [Ca2+]I elevation, CGP37157 reduced m-calpain activity, which is involved in NMDAR-mediated neurodegeneration.36 On the other hand, consistent with its regulation of [Ca2+]I and [Ca2+]mit during excitotoxicity, nifedipine was as efficient as CGP37157 in protecting neurons against NMDA-induced neuronal death and the effects of both inhibitors were not additive. Although inhibition of the NCLX may also contribute to neuroprotection through the prevention of the mitochondrial futile Ca2+ cycling37 and the modulation of SOCE, we conclude that the neuroprotective effect by CGP37157 during NMDA receptor-mediated excitotoxicity relies mainly on VGCC blockade and the attenuation of intracellular Ca2+ overload. Indeed, L-type VGCCs are considered as relevant contributors to excitotoxicity, in particular in mature neurons15 and late stages of glutamate-mediated injury.16 The multi-target effect of CGP37157 described here may represent a potential therapeutic strategy in neurological disorders involving excitotoxicity and intracellular Ca2+ homeostasis disruption.
Materials and Methods
Animals
All experiments were conducted under the supervision and with the approval of our internal animal ethics committee (University of the Basque Country, UPV/EHU). Animals were handled in accordance with the European Communities Council Directive. All possible efforts were made to minimize animal suffering and the number of animals used.
Reagents and plasmids
Neurobasal medium, B27 supplement, calcein-AM (calcein acetoxymethyl ester), CM-H2DCFDA and JC-1 were purchased from Invitrogen (Barcelona, Spain). NMDA, HBSS, glycine, poly-L-ornithine, thapsigargin and nifedipine were obtained from Sigma (St. Louis, MO, USA). CGP37157 (7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one) was obtained from Tocris Biosciences (Minneapolis, MN, USA). Cytotox 96 for LDH release quantification was purchased from Promega (Madison, WI, USA).
The plasmid expressing mitochondria-targeted Ca2+ indicator (2mtD4cpv) was kindly provided by Roger Tsien (University of California, San Diego, La Jolla, CA, USA). Mitochondrial DsRed expressing plasmid was obtained from Clontech (Takara Bio Inc., Otsu, Japan).
Neuronal primary culture and transfection procedures
Cortical neurons were obtained from the cortical lobes of E18 Sprague–Dawley rat embryos according to previously described procedures.38, 39 Neurons were resuspended in B27 Neurobasal medium plus 10% FBS and then seeded onto poly-L-ornithine-coated 48-well plates or glass coverslips (12 mm in diameter) at 1.5 × 105 cells per well. For confocal single-cell imaging experiments, cells were plated onto glass-bottom μ-dishes (Ibidi GmbH, Planegg/Martinsried, Germany). The medium was replaced by serum-free, B27-supplemented Neurobasal medium 24 h later. The cultures were essentially free of astrocytes and microglia and were maintained at 37 °C and 5% CO2. Cultures were used at 8–9 days in vitro.
For transfection of cells, 4 × 106 rat neurons were transfected in suspension before plating with 3 μg of cDNA using Rat Neuron Nucleofector Kit (Lonza, Basel, Switzerland) according to the manufacturer instructions and plated and maintained as described above.
Immunocytochemistry
For NCLX expression analysis, eight DIV mtDsRed-transfected neurons were fixed with 4% paraformaldehyde for 20 min and permeabilized in 1% BSA, 1% normal serum, 0.05% Triton X-100 in PBS for 30 min. Then, cells were blocked in 10% BSA, 1% normal serum in PBS for 1 h and incubated overnight at 4 °C with anti-NCLX (1 : 500, LifeSpan BioSciences, Seattle, WA, USA) in 1% BSA, 1% normal serum in PBS. After washing with PBS, Alexa Fluor 488-conjugated secondary antibody (1 : 200, Molecular Probes, Barcelona, Spain) was added for 1 h. Finally, coverslips were washed in PBS and mounted using ProLong Gold mounting medium (Invitrogen). Controls without a primary antibody showed no staining. Images were aquired by a TCS SP8X confocal microscope (Leica, Wetzlar, Germany) and deconvolution and fluorescence intensity plot were performed by Huygens software (SVI, Hilversum, The Netherlands). For colocalization quantification, neuronal bodies of several cells were selected as ROIs and Overlap Coefficient was calculated using Leica LAS AF software.
Western blotting
Cells (triplicates of 1.5 × 104) were washed with PBS and harvested in 50 μl of ice-cold electrophoresis sample buffer. Lysates were boiled for 10 min, separated by electrophoresis using Criterion TGX Precast 12% gels and transferred to Trans-Blot Turbo Midi Nitrocellulose Transfer Packs (Bio-Rad, Hercules, CA, USA). For immunoblotting, membranes were blocked in 5% skimmed milk, 5% serum in TBST and proteins detected by specific primary antibodies in 5% BSA in TBST overnight at 4 °C: anti-NCLX (1 : 1000; LifeSpan Biosciences); anti-caspase-3 (1 : 1000, Santa Cruz Biotechnology, Dallas, TX, USA); anti-PARP (1 : 1000, Cell Signaling, Danvers, MA, USA). After washing, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (1 : 2000, Sigma) in 5% skimmed milk, 1% normal serum in TTBS for 2 h RT and developed using enhanced chemiluminiscence according to the manufacturer’s instructions (Super Signal West Dura, Pierce, Rockford, IL, USA). In quantitative immunoblotting experiments, signals were quantified using Image-J software (NIH, Bethesda, MD, USA) and values were normalized to β-actin signal and provided as the mean±S.E.M. of at least three independent experiments.
Cytosolic Na+ and Ca2+ imaging
For [Ca2+]i measurements, neurons were loaded with Fluo-4 AM (1 μM; Molecular Probes, Invitrogen) in Ca2+ and Mg2+ free HBSS containing 20 mM HEPES, pH 7.4, 10 mM glucose, 10 μM glycine and 2.6 mM CaCl2 (incubation buffer) for 30 min at 37 °C followed by 20 min wash to allow de-esterification. For cytosolic Na+ imaging, cells were loaded with Sodium Green tetraacetate (5 μM, 1 h) and pluronic acid (0.025% w/v, Invitrogen) followed by 30 min wash in incubation buffer. Images were acquired through a 63X objective by inverted LCS SP2 confocal microscope (Leica) at an acquisition rate of one frame/15 s for 5 or 10 min depending on the experiment. Both Fluo-4 AM- and Sodium Green-loaded cells were excited at 488 nm. For data analysis, a homogeneous population of 15–25 cells was selected in the field of view and neuronal somata selected as ROIs. Background values were always subtracted and data are expressed as F/F0±S.E.M. (%) in which F represents the fluorescence value for a given time point and F0 represents the mean of the resting level fluorescence.
Mitochondrial Ca2+ imaging
Neurons transfected with mitochondria-targeted 2mtD4cpv Ca2+ indicator40 were transferred to incubation buffer (see above) and imaged by a TCS SP8X confocal microscope (Leica). Cells were excited at 458 nm and cfp and yfp emission acquired for FRET ratio quantification at an acquisition rate of one frame/15 s for 5 or 10 min depending on the experiment. For data analysis, a homogeneous population of 5–12 cells was selected in the field of view and neuronal somata selected as ROIs. Background values were always subtracted and data are expressed as R/R0±S.E.M. (%) in which R represents the yfp/cpf fluorescence ratio for a given time point and R0 represents the mean of the resting FRET ratio.
Neuronal toxicity assays
Cell toxicity assays were performed as described previously41 with modifications. Neurons were exposed to NMDA in HBSS (free of Ca2+ and Mg2+) containing 2.6 mM CaCl2, 10 mM glucose and 10 μM glycine for 10 or 30 min at 37 °C, depending on the experiment. Antagonists were present before and during the excitotoxic insult and cell viability was assessed 24 h later using Citotox 96 colorimetric assay (Promega). All experiments were performed in quadruplicate and the values provided are the normalized mean±S.E.M. of at least three independent experiments.
Intracellular reactive oxygen species (ROS) and mitochondrial membrane potential measurements
Neurons were stimulated with NMDA for 10 min in the absence or presence of antagonists and loaded with 5-(and 6)-chloromethyl-2′7′-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2 DCFDA) for 30 min for the measurement of generated ROS. Calcein-AM (1 μM) was used to quantify the number of cells within the reading field and fluorescence was measured as described previously.42 For quantification of mitochondrial membrane potential, cells were loaded 30 min after the excitotoxic stimulus with JC-1 dye for 15 min and red/green fluorescence ratio was measured. All experiments were performed in quadruplicate and the values provided are the normalized mean±S.E.M. of at least three independent experiments.
Data analysis
All data are expressed as mean±S.E.M. (n), where n refers to the number of cultures assayed, each obtained from a different group of animals. In single cell Ca2+ imaging experiments, n refers to number of cells recorded from at least three independent cultures obtained from different groups of animals. For statistical analysis of the [Ca2+] and [Na+] increase or accumulation, basal line-extracted area under curve was calculated from single cell imaging time-lapses. Ca2+ efflux was represented as the declining slope of the [Ca2+] time course as described before.4 Statistical analysis was carried out with Student’s t-test and significance was determined at P<0.05.
Abbreviations
- NCLX:
-
mitochondrial Na+/Ca2+ exchanger
- CGP37157:
-
7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepin-2(3H)-one
- VGCC:
-
voltage-gated calcium channel
- NMDA:
-
N-methyl-D-aspartate
- ER:
-
endoplasmic reticulum
- SERCA:
-
sarcoplasmic reticulum Ca2+ ATP-ase
- RyR:
-
ryanodine receptor
- LDH:
-
lactate dehydrogenase
- ROS:
-
reactive oxygen species
References
Nicholls DG . Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta 2009; 1787: 1416–1424.
Drago I, Pizzo P, Pozzan T . After half a century mitochondrial calcium in- and efflux machineries reveal themselves. EMBO J 2011; 30: 4119–4125.
Pizzo P, Drago I, Filadi R, Pozzan T . Mitochondrial Ca2+ homeostasis: mechanism, role, and tissue specificities. Pflugers Arch 2012; 464: 3–17.
Palty R, Silverman WF, Hershfinkel M, Caporale T, Sensi SL, Parnis J et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci USA 2010; 107: 436–441.
Cox DA, Conforti L, Sperelakis N, Matlib MA . Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol 1993; 21: 595–599.
Palty R, Sekler I . The mitochondrial Na+/Ca2+ exchanger. Cell Calcium 2012; 52: 9–15.
Castaldo P, Cataldi M, Magi S, Lariccia V, Arcangeli S, Amoroso S . Role of the mitochondrial sodium/calcium exchanger in neuronal physiology and in the pathogenesis of neurological diseases. Prog Neurobiol 2009; 87: 58–79.
Nicolau SM, Egea J, López MG, García AG . Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices. Biochem Biophys Res Commun 2010; 400: 140–144.
Gandhi S, Wood-kaczmar A, Yao Z, Plun-favreau H, Deas E, Klupsch K et al. PINK1-associated Parkinson´s disease is caused by neuronal vulnerability to calcium-induced cell death. Molecular Cell 2009; 33: 627–638.
Choi DW . Excitotoxic cell death. J Neurobiol 1992; 23: 1261–1276.
Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ . Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998; 1: 366–373.
Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB . Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci USA 2009; 106: 9854–9859.
Starkov AA, Chinopoulos C, Fiskum G . Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 2004; 36: 257–264.
Wang KK . Calpain and caspase: can you tell the difference? Trends Neurosci 2000; 23: 20–26.
Brewer LD, Thibault O, Staton J, Thibault V, Rogers JT, Garcia-Ramos G et al. Increased vulnerability of hippocampal neurons with age in culture: temporal association with increases in NMDA receptor current, NR2A subunit expression and recruitment of L-type calcium channels. Brain Res 2007; 1151: 20–31.
Prehn JH, Lippert K, Krieglstein J . Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur J Pharmacol 1995; 292: 179–189.
Cai X, Lytton J . Molecular cloning of a sixth member of the K+-dependent Na+/Ca2+ exchanger gene family, NCKX6. J Biol Chem 2004; 279: 5867–5876.
Csordás G, Várnai P, Golenár T, Sheu SS, Hajnóczky G . Calcium transport across the inner mitochondrial membrane: molecular mechanisms and pharmacology. Mol Cell Endocrinol 2012; 353: 109–113.
Baron KT, Thayer SA . CGP37157 modulates mitochondrial Ca2+ homeostasis in cultured rat dorsal root ganglion neurons. Eur J Pharmacol 1997; 340: 295–300.
Luciani DS, Ao P, Hu X, Warnock GL, Johnson JD . Voltage-gated Ca2+ influx and insulin secretion in human and mouse beta-cells are impaired by the mitochondrial Na+/Ca2+ exchange inhibitor CGP-37157. Eur J Pharmacol 2007; 576: 18–25.
Lee B, Miles PD, Vargas L, Luan P, Glasco S, Kushnareva Y et al. Inhibition of mitochondrial Na+-Ca2+ exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic islets. Diabetes 2003; 52: 965–973.
Neumann JT, Diaz-sylvester PL, Fleischer S, Copello JA . CGP-37157 inhibits the sarcoplasmic reticulum Ca2+ ATPase and activates ryanodine receptor channels in striated muscle. Mol Pharmacol 2011; 79: 141–147.
González-Lafuente L, Egea J, León R, Martínez-Sanz FJ, Monjas L, Perez C et al. Benzothiazepine CGP37157 and its isosteric 2’-methyl analogue provide neuroprotection and block cell calcium entry. ACS Chem Neurosci 2012; 3: 519–529.
Parnis J, Montana V, Delgado-Martinez I, Matyash V, Parpura V, Kettenmann H et al. Mitochondrial exchanger NCLX plays a major role in the intracellular Ca2+ signaling, gliotransmission, and proliferation of astrocytes. J Neurosci 2013; 33: 7206–7219.
Peng TI, Greenamyre JT . Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. Mol Pharmacol 1998; 53: 974–980.
Ruiz A, Matute C, Alberdi E . Endoplasmic reticulum Ca2+ release through ryanodine and IP(3) receptors contributes to neuronal excitotoxicity. Cell Calcium 2009; 46: 273–281.
Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of “pathological apoptosis”? J Biol Chem 2001; 276: 10191–10198.
Lankiewicz S . Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J Biol Chem 2000; 275: 17064–17071.
Zhang C, Shen W, Zhang G . N-methyl-D-aspartate receptor and L-type voltage-gated Ca(2+) channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischemia. Neurosci Lett 2002; 328: 265–268.
Zhang Y, Lipton P . Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria. J Neurosci 1999; 19: 3307–3315.
Chiesi M, Schwaller R, Eichenberger K . Structural dependency of the inhibitory action of benzodiazepines and related compounds on the mitochondrial Na+-Ca2+ exchanger. Biochem Pharmacol 1988; 37: 4399–4403.
Arundine M, Tymianski M . Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61: 657–668.
White RJ, Reynolds IJ . Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones. J Physiol 1997; 498 (Pt 1): 31–47.
Scanlon JM, Brocard JB, Stout AK, Reynolds IJ . Pharmacological investigation of mitochondrial Ca2+ transport in central neurons: studies with CGP-37157, an inhibitor of the mitochondrial Na+-Ca2+ exchanger. Cell Calcium 2000; 28: 317–327.
Duchen MR . Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000; 529 (Pt 1): 57–68.
Wang Y, Briz V, Chishti A, Bi X, Baudry M . Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. J Neurosci 2013; 33: 18880–18892.
Fernández-Morales JC, Arranz-Tagarro JA, Calvo-Gallardo E, Maroto M, Padín JF, García AG . Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer’s disease. ACS Chem Neurosci 2012; 3: 873–883.
Larm JA, Cheung NS, Beart PM . (S)-5-fluorowillardiine-mediated neurotoxicity in cultured murine cortical neurones occurs via AMPA and kainate receptors. Eur J Pharmacol 1996; 314: 249–254.
Cheung NS, Pascoe CJ, Giardina SF, John CA, Beart PM . Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurones. Neuropharmacology 1998; 37: 1419–1429.
Palmer AE, Giacomello M, Kortemme T, Hires SA, Lev-Ram V, Baker D et al. Ca2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem Biol 2006; 13: 521–530.
Schubert D, Kimura H, Maher P . Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 1992; 89: 8264–8267.
Campos-Esparza MR, Sánchez-Gómez MV, Matute C . Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium 2009; 45: 358–368.
Acknowledgements
This work was supported by CIBERNED, MINECO, Gobierno Vasco and the University of País Vasco. We thank Dr. Szabadkai and Dr. Duchen at the University College of London for their help in setting up the mitochondrial Ca2+ imaging approaches.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by D Bano
Rights and permissions
Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ruiz, A., Alberdi, E. & Matute, C. CGP37157, an inhibitor of the mitochondrial Na+/Ca2+ exchanger, protects neurons from excitotoxicity by blocking voltage-gated Ca2+ channels. Cell Death Dis 5, e1156 (2014). https://doi.org/10.1038/cddis.2014.134
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2014.134
Keywords
This article is cited by
-
Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses
Molecular Biology Reports (2024)
-
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Cell Death & Disease (2020)
-
Selective inhibition of mitochondrial sodium-calcium exchanger protects striatal neurons from α-synuclein plus rotenone induced toxicity
Cell Death & Disease (2019)
-
Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure
Current Heart Failure Reports (2017)
-
Comparative Microarray Analysis Identifies Commonalities in Neuronal Injury: Evidence for Oxidative Stress, Dysfunction of Calcium Signalling, and Inhibition of Autophagy–Lysosomal Pathway
Neurochemical Research (2016)